Skadden advised Terumo Corporation, a leading medical device manufacturer, in the ¥182.5 billion (approximately US$1.3 billion) Rule 144A/Regulation S secondary offering of its common stock.
The offering of 73,211,900 shares of common stock at ¥2,493.5 (US$17.51) per share closed on September 13, 2024. Terumo Corporation is listed on the Prime Market of the Tokyo Stock Exchange.
The team includes corporate partner Kenji Taneda; with counsel Ken Kiyota; Asia Pacific counsel Tatsuya Hasegawa; and associates Liam Kantor, Tetsuya Kumamoto and Atsuko Onishi. All attorneys are located in Tokyo.
